Our experts have managed commercial functions from every side of the business, as directors and vice presidents, within start-up biotechnology companies and large biopharmaceutical organizations. Most importantly, our team is in touch with the current issues and dynamics associated with today’s healthcare marketplace, as our experience is vast but also recent.

Because of our experience, we are able to better understand your commercialization needs, as we know what it takes to launch and support products in today’s challenging marketplace. We are confident that our experience can be of value to your organization in developing and executing the most successful commercialization plan.

Our Reimbursement Expertise
The Palomino Group offers comprehensive strategic and tactical reimbursement support based upon the extensive reimbursement experience of our team. Our staff has successfully supported reimbursement coverage for hundreds of leading oncology agents, innovative pharmaceuticals, and medical device products, and possesses experience across core disease areas including oncology, HIV, cardiology, rheumatology, infectious disease, diabetes, and rare disorders.

Our team has completed numerous strategic reimbursement analyses and market assessments and is experienced in all areas of strategic and tactical reimbursement support. Our core competencies include the planning and development of reimbursement strategies for products in all stages of development and commercialization. Our principals have also pioneered the development of innovative “call-center” support programs that are seamlessly integrated across all key manufacturer, distributor, healthcare provider, and patient-related points of contact.

Most importantly, the Palomino Group team experience combines an understanding of the needs of the biopharmaceutical manufacturer with the experience of leading reimbursement consulting experts. As a result, we are able to offer our clients the highest level of quality service and support.